CTCBIO Inc Market Cap ($42.37 Million)
Market Cap & Net Worth: CTCBIO Inc (060590)
CTCBIO Inc market cap. CTCBIO Inc (KQ:060590) has a market capitalization of $42.37 Million (₩62.52 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22327 globally and #1421 in its home market, demonstrating a -3.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CTCBIO Inc's stock price ₩2615.00 by its total outstanding shares 23908775 (23.91 Million). Also see cash flow conversion of CTCBIO Inc for how efficiently the company converts equity into cash flow.
CTCBIO Inc Market Cap History (2015–2026)
CTCBIO Inc market cap history from 2015 to 2026. Data shows change from $249.52 Million to $42.37 Million (-15.61% CAGR). Check 060590 live share price for real-time trading data and today's change.
Index Memberships
CTCBIO Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$211.91 Billion | 0.02% | #681 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$211.91 Billion | 0.02% | #681 of 1384 |
Weight: CTCBIO Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CTCBIO Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CTCBIO Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CTCBIO Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
CTCBIO Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $249.52 Million | $118.99 Billion | $2.74 Billion | 0.00x | 0.09x |
| 2016 | $170.13 Million | $123.15 Billion | -$2.74 Billion | 0.00x | N/A |
| 2017 | $209.01 Million | $130.56 Billion | -$20.70 Billion | 0.00x | N/A |
| 2018 | $131.24 Million | $138.40 Billion | -$9.06 Billion | 0.00x | N/A |
| 2019 | $98.84 Million | $136.12 Billion | -$13.74 Billion | 0.00x | N/A |
| 2020 | $124.92 Million | $130.03 Billion | -$19.46 Billion | 0.00x | N/A |
| 2021 | $146.80 Million | $140.32 Billion | -$7.32 Billion | 0.00x | N/A |
| 2022 | $102.08 Million | $165.21 Billion | $6.75 Billion | 0.00x | 0.02x |
| 2023 | $173.37 Million | $137.88 Billion | -$15.59 Billion | 0.00x | N/A |
| 2024 | $106.13 Million | $144.41 Billion | -$5.22 Billion | 0.00x | N/A |
Competitor Companies of 060590 by Market Capitalization
Companies near CTCBIO Inc in the global market cap rankings as of November 3, 2026. Also see CTCBIO Inc assets under control for a full breakdown of the balance sheet.
Key companies related to CTCBIO Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of CTCBIO Inc (2015–2026)
Market capitalization of CTCBIO Inc from 2015 to today. Between 2015 and today, CTCBIO Inc's market cap moved from $249.52 Million to $ 42.37 Million, with a yearly change of -15.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩42.37 Million | -43.46% |
| 2025 | ₩74.94 Million | -29.39% |
| 2024 | ₩106.13 Million | -38.79% |
| 2023 | ₩173.37 Million | +69.84% |
| 2022 | ₩102.08 Million | -30.46% |
| 2021 | ₩146.80 Million | +17.51% |
| 2020 | ₩124.92 Million | +26.39% |
| 2019 | ₩98.84 Million | -24.69% |
| 2018 | ₩131.24 Million | -37.21% |
| 2017 | ₩209.01 Million | +22.86% |
| 2016 | ₩170.13 Million | -31.82% |
| 2015 | ₩249.52 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of CTCBIO Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.37 Million USD |
| MoneyControl | $42.37 Million USD |
| MarketWatch | $42.37 Million USD |
| marketcap.company | $42.37 Million USD |
| Reuters | $42.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CTCBIO Inc
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergi… Read more